Published in Stat Med on May 19, 2016
Accounting for competing risks in randomized controlled trials: a review and recommendations for improvement. Stat Med (2017) 0.75
Prediction of the 20-year incidence of diabetes in older Chinese: Application of the competing risk method in a longitudinal study. Medicine (Baltimore) (2016) 0.75
A competing-risk-based score for predicting twenty-year risk of incident diabetes: the Beijing Longitudinal Study of Ageing study. Sci Rep (2016) 0.75
Prediction of coronary heart disease using risk factor categories. Circulation (1998) 48.81
Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA (2001) 16.98
Factors of risk in the development of coronary heart disease--six year follow-up experience. The Framingham Study. Ann Intern Med (1961) 12.08
Tutorial in biostatistics: competing risks and multi-state models. Stat Med (2007) 10.61
Dichotomizing continuous predictors in multiple regression: a bad idea. Stat Med (2006) 8.25
A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA (2004) 7.32
Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med (2003) 7.25
Presentation of multivariate data for clinical use: The Framingham Study risk score functions. Stat Med (2004) 6.42
Predicting mortality among patients hospitalized for heart failure: derivation and validation of a clinical model. JAMA (2003) 6.39
A note on competing risks in survival data analysis. Br J Cancer (2004) 5.60
TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation (2000) 5.15
Competing risk regression models for epidemiologic data. Am J Epidemiol (2009) 4.75
Predicting the 30-year risk of cardiovascular disease: the framingham heart study. Circulation (2009) 4.62
Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data? Stat Med (1993) 4.60
Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41,021 patients. GUSTO-I Investigators. Circulation (1995) 3.38
Prediction of cumulative incidence function under the proportional hazards model. Biometrics (1998) 3.32
Prognostic models with competing risks: methods and application to coronary risk prediction. Epidemiology (2009) 3.20
Effectiveness of public report cards for improving the quality of cardiac care: the EFFECT study: a randomized trial. JAMA (2009) 3.08
Framingham risk score and prediction of lifetime risk for coronary heart disease. Am J Cardiol (2004) 2.89
Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study. Circulation (2008) 2.57
Computing estimates of incidence, including lifetime risk: Alzheimer's disease in the Framingham Study. The Practical Incidence Estimators (PIE) macro. Stat Med (2000) 2.54
Estimates of absolute cause-specific risk in cohort studies. Biometrics (1990) 2.42
Effectiveness and acceptability of a computerized decision support system using modified Wells criteria for evaluation of suspected pulmonary embolism. Ann Emerg Med (2010) 2.19
Competing risk of death: an important consideration in studies of older adults. J Am Geriatr Soc (2010) 2.01
A competing risks analysis should report results on all cause-specific hazards and cumulative incidence functions. J Clin Epidemiol (2013) 1.92
Evaluating health outcomes in the presence of competing risks: a review of statistical methods and clinical applications. Med Care (2010) 1.88
Inflation of the type I error rate when a continuous confounding variable is categorized in logistic regression analyses. Stat Med (2004) 1.86
Competing risks and the clinical community: irrelevance or ignorance? Stat Med (2011) 1.80
Should scoring rules be based on odds ratios or regression coefficients? J Clin Epidemiol (2002) 1.58
Clinical Risk Stratification for Primary Prevention Implantable Cardioverter Defibrillators. Circ Heart Fail (2015) 1.53
Concordance for prognostic models with competing risks. Biostatistics (2014) 1.38
Competing risks analyses: objectives and approaches. Eur Heart J (2014) 1.35
Use of the CHA(2)DS(2)-VASc and HAS-BLED scores to aid decision making for thromboprophylaxis in nonvalvular atrial fibrillation. Circulation (2012) 1.34
TIMI, GRACE and alternative risk scores in Acute Coronary Syndromes: a meta-analysis of 40 derivation studies on 216,552 patients and of 42 validation studies on 31,625 patients. Contemp Clin Trials (2012) 1.26
Introduction to the Analysis of Survival Data in the Presence of Competing Risks. Circulation (2016) 1.17
Patient death as a censoring event or competing risk event in models of nursing home placement. Stat Med (2010) 1.04
Cardiovascular Disease Risk Assessment: Insights from Framingham. Glob Heart (2013) 0.98
Mapping the Terrain of Competing Risk Following Primary Prevention Defibrillator Implantation. Circ Heart Fail (2015) 0.77